University of Southern California


RFA-AR-21-002: NIAMS Rheumatic Diseases Research Resource-based Centers (P30 – Clinical Trial Not Allowed)

Slots:                                        1

Internal Deadline:        June 5, 2020

LOI:                                          30 days prior to the application due date

External Deadline:                     October 6, 2020

Award Information:                   Type: Grant

Estimated Number of Awards: See below.

Anticipated Amount: NIAMS intends to commit up to $2.0 million direct costs in FY2021 to fund a maximum of four awards.

Submission Process: To apply to any of the limited submissions, PIs must submit their application as a Limited Submission through the Office of Research Application Portal:

Materials to submit include:


Who May Serve as PI:                    Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

Purpose:                                   The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.